1. Microelimination of Hepatitis C in Patients with Substance Use and Dual Disorders - a Portuguese Study.
- Author
-
Faria I, Facão R, Murta F, Carvalho R, Silva C, Murta I, and Valente C
- Subjects
- Humans, Male, Middle Aged, Portugal epidemiology, Female, Prospective Studies, Adult, Prevalence, Aged, RNA, Viral blood, Mental Disorders epidemiology, Hepacivirus immunology, Hepatitis C epidemiology, Young Adult, Substance-Related Disorders epidemiology, Substance-Related Disorders complications, Hepatitis C Antibodies blood, Hepatitis C, Chronic epidemiology
- Abstract
Chronic hepatitis C (CHC) is a serious condition of public health importance. In Portugal, the prevalence of detectable hepatitis C virus (HCV) antibodies is approximately 0.54%, with a higher prevalence in high-risk groups. Compared with the general population, the prevalence of HCV infection is higher in individuals with psychiatric disorders. As no studies have reported the prevalence of HCV antibodies in Portuguese patients with psychiatric conditions and substance use disorders, we conducted an observational, prospective study of patients followed in the Dual Pathology Outpatient and Inpatient Unit of Coimbra Hospital and University Center (CHUC), Patients were tested for HCV antibodies. Of the 149 patients, 17.4% were positive for HCV antibodies and 7.4% had detectable HCV RNA indicating CHC. Most patients with confirmed CHC were male inpatients, aged 50 to 59 years, and reported unprotected sex with more than one concurrent partner in the past 6 months. Their most common psychiatric diagnosis was "Disorders due to use of multiple specified psychoactive substances, including medications." The prevalence of HCV antibodies and confirmed CHC were higher in patients followed in the Dual Pathology Outpatient and Inpatient Unit than in the general Portuguese population.
- Published
- 2024
- Full Text
- View/download PDF